SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc – ‘10-K’ for 12/31/14 – ‘EX-32.1’

On:  Tuesday, 2/10/15, at 4:45pm ET   ·   For:  12/31/14   ·   Accession #:  731766-15-7   ·   File #:  1-10864

Previous ‘10-K’:  ‘10-K’ on 2/12/14 for 12/31/13   ·   Next:  ‘10-K’ on 2/9/16 for 12/31/15   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/10/15  Unitedhealth Group Inc            10-K       12/31/14  111:26M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.49M 
 2: EX-10.2     Material Contract                                   HTML     35K 
 3: EX-10.3     Material Contract                                   HTML     83K 
 4: EX-10.32    Material Contract                                   HTML     57K 
 6: EX-21.1     Subsidiaries List                                   HTML    128K 
 7: EX-23.1     Consent of Experts or Counsel                       HTML     34K 
 8: EX-24.1     Power of Attorney                                   HTML     40K 
 5: EX-12.1     Statement re: Computation of Ratios                 HTML     45K 
 9: EX-31.1     Certification -- §302 - SOA'02                      HTML     48K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     36K 
76: R1          Document and Entity Information Document            HTML     63K 
62: R2          Consolidated Balance Sheets                         HTML    152K 
73: R3          Consolidated Balance Sheet (Parenthetical)          HTML     68K 
80: R4          Consolidated Statements of Operations               HTML    123K 
101: R5          Consolidated Statements of Comprehensive Income     HTML     82K  
64: R6          Consolidated Statements of Changes in               HTML    113K 
                Shareholders' Equity                                             
72: R7          Consolidated Statements of Cash Flows               HTML    162K 
55: R8          Description of Business (Notes)                     HTML     33K 
45: R9          Basis of Presentation, Uses of Estimates and        HTML    128K 
                Significant Accounting Policies (Notes)                          
103: R10         Investments (Notes)                                 HTML    297K  
82: R11         Fair Value (Notes)                                  HTML    336K 
81: R12         Property, Plant, and Capitalized Software (Notes)   HTML     55K 
88: R13         Goodwill and Intangible Assets (Notes)              HTML    120K 
89: R14         Medical Cost Reserve Development and Medical Costs  HTML     61K 
                Payable (Notes)                                                  
86: R15         Commercial Paper and Long-Term Debt (Notes)         HTML    222K 
90: R16         Income Taxes (Notes)                                HTML    155K 
74: R17         Shareholders' Equity (Notes)                        HTML     57K 
77: R18         Share-Based Compensation (Notes)                    HTML    115K 
84: R19         Commitments and Contingencies (Notes)               HTML     58K 
111: R20         Segment Financial Information (Notes)               HTML    317K  
97: R21         Quarterly Financial Data (Unaudited) (Notes)        HTML     85K 
68: R22         Schedule I (Notes)                                  HTML    191K 
83: R23         Basis of Presentation, Uses of Estimates and        HTML    195K 
                Significant Accounting Policies (Policies)                       
70: R24         Fair Value Fair Value (Policies)                    HTML     48K 
36: R25         Basis of Presentation, Uses of Estimates and        HTML     88K 
                Significant Accounting Policies (Tables)                         
98: R26         Investments (Tables)                                HTML    300K 
107: R27         Fair Value (Tables)                                 HTML    329K  
50: R28         Property, Plant, and Capitalized Software (Tables)  HTML     53K 
49: R29         Goodwill and Intangible Assets (Tables)             HTML    123K 
53: R30         Medical Cost Reserve Development and Medical Costs  HTML     62K 
                Payable (Tables)                                                 
54: R31         Commercial Paper and Long-Term Debt (Tables)        HTML    226K 
57: R32         Income Taxes (Tables)                               HTML    177K 
25: R33         Shareholders' Equity (Tables)                       HTML     41K 
95: R34         Share-Based Compensation (Tables)                   HTML    115K 
66: R35         Commitments and Contingencies Commitments and       HTML     43K 
                Contingencies (Tables)                                           
69: R36         Segment Financial Information (Tables)              HTML    302K 
40: R37         Quarterly Financial Data (Unaudited) (Tables)       HTML     84K 
110: R38         Schedule I (Tables)                                 HTML    197K  
17: R39         Basis of Presentation, Uses of Estimates and        HTML     84K 
                Significant Accounting Policies (Details)                        
59: R40         Basis of Presentation, Uses of Estimates and        HTML     46K 
                Significant Accounting Policies Medicare Part D                  
                (Details)                                                        
100: R41         Basis of Presentation, Uses of Estimates and        HTML     45K  
                Significant Accounting Policies Useful lives for                 
                property, equipment and capitalized software                     
                (Details)                                                        
38: R42         Basis of Presentation, Uses of Estimates and        HTML     53K 
                Significant Accounting Policies Redeemable                       
                Noncontrolling Interests (Details)                               
48: R43         Investments (Narrative) (Details)                   HTML     36K 
52: R44         Investments (Short-Term and Long-Term Investments)  HTML    137K 
                (Details)                                                        
63: R45         Investments (Fair Value of Mortgage-Backed          HTML    114K 
                Securities by Credit Rating Origination) (Details)               
24: R46         Investments (Amortized Cost and Fair Value of       HTML     87K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
44: R47         Investments (Amortized Cost and Fair Value of       HTML     66K 
                Held-To-Maturity Debt Securities by Contractual                  
                Maturity) (Details)                                              
19: R48         Investments (Fair Value of Available-For-Sale       HTML    117K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
99: R49         Investments (Net Realized Gains) (Details)          HTML     72K 
37: R50         Fair Value (Narrative) (Details)                    HTML     61K 
96: R51         Fair Value (Financial Assets and Liabilities,       HTML    145K 
                Excluding AARP, Measured at Fair Value on a                      
                Recurring Basis) (Details)                                       
41: R52         Fair Value (Financial Assets and Liabilities,       HTML    127K 
                Excluding AARP, Not Measured at Fair Value on a                  
                Recurring Basis) (Details)                                       
60: R53         Fair Value (Reconciliation of Assets Measured at    HTML     98K 
                Fair Value on a Recurring Basis Using Level 3                    
                Inputs) (Details)                                                
18: R54         Fair Value Fair Value Inputs Assets Quantitative    HTML     52K 
                Information (Details)                                            
22: R55         Fair Value (Assets and Liabilities measured at      HTML    189K 
                fair value on a recurring basis) (Details)                       
51: R56         Property, Plant, and Capitalized Software           HTML     38K 
                (Details)                                                        
29: R57         Property, Plant, and Capitalized Software Property  HTML     62K 
                Plant and Equipment Table (Details)                              
104: R58         Goodwill and Intangible Assets (Details)            HTML     36K  
65: R59         Goodwill and Intangible Assets Changes in the       HTML     64K 
                Carrying Amount of Goodwill by Reporting Segment                 
                (Details)                                                        
87: R60         Goodwill and Intangible Assets Gross carrying       HTML     63K 
                value, accumulated amortization and net carrying                 
                value of intangible assets (Details)                             
43: R61         Goodwill and Intangible Assets Weighted-average     HTML     48K 
                useful lives assigned to finite-lived intangible                 
                assets acquired in business combinations (Details)               
46: R62         Goodwill and Intangible Assets Amortization         HTML     45K 
                Expense relating to Intangible Assets (Details)                  
94: R63         Medical Costs and Medical Costs Payable             HTML     58K 
                Rollforward (Details)                                            
91: R64         Commercial Paper and Long-Term Debt (Narrative)     HTML     73K 
                (Details)                                                        
67: R65         Commercial Paper and Long-Term Debt (Details)       HTML    271K 
93: R66         Commercial Paper and Long-Term Debt Maturities of   HTML     51K 
                commercial paper and long-term debt (Details)                    
42: R67         Commercial Paper and Long-Term Debt Fair Value      HTML     46K 
                Hedges Statement of Financial Position Location                  
                (Details)                                                        
71: R68         Commercial Paper and Long-Term Debt Fair Value      HTML     48K 
                Hedges Effect of Changes in Fair Value Hedges on                 
                Income (Details)                                                 
106: R69         Income Taxes (Details)                              HTML     64K  
21: R70         Income Taxes Reconciliation of Provision for        HTML     54K 
                Income Taxes (Details)                                           
35: R71         Income Tax Reconciliation of the tax provision at   HTML     84K 
                the U.S. Federal Statutory Rate (Details)                        
61: R72         Income Taxes Components of Deferred Tax Assets and  HTML    102K 
                Liabilities (Details)                                            
27: R73         Income Taxes Reconciliation of the beginning and    HTML     53K 
                ending amount of unrecognized tax benefits                       
                (Details)                                                        
109: R74         Shareholders' Equity (Details)                      HTML     70K  
39: R75         Shareholders' Equity Dividends Paid (Details)       HTML     38K 
30: R76         Share-Based Compensation Narrative (Details)        HTML     44K 
34: R77         Share-Based Compensation (Stock Option and SAR      HTML     86K 
                Activity) (Details)                                              
23: R78         Share-Based Compensation (Restricted Share          HTML     53K 
                Activity) (Details)                                              
26: R79         Share-Based Compensation Other Share-Based          HTML     75K 
                Compensation Data (Details)                                      
78: R80         Share-Based Compensation (Share-Based Compensation  HTML     64K 
                Principal Fair Value Assumptions) (Details)                      
32: R81         Commitments and Contingencies (Details)             HTML     70K 
105: R82         Commitments and Contingencies Future Lease          HTML     50K  
                Payments (Details)                                               
58: R83         Segment Financial Information (Narrative)           HTML     49K 
                (Details)                                                        
85: R84         Segment Financial Information (Details)             HTML    261K 
92: R85         Quarterly Financial Data (Unaudited) (Details)      HTML     87K 
31: R86         Schedule I (Details)                                HTML     65K 
33: R87         Schedule I Condensed Balance Sheets (Details)       HTML    132K 
102: R88         Schedule I Balance Sheet Document (Details)         HTML     64K  
28: R89         Schedule I Condensed Statement of Comprehensive     HTML     88K 
                Income (Details)                                                 
79: R90         Schedule I Statement of Cash Flows (Details)        HTML    127K 
75: R91         Schedule I Maturities of Commercial Paper and       HTML     56K 
                Long-Term Debt (Details)                                         
108: XML         IDEA XML File -- Filing Summary                      XML    169K  
20: EXCEL       IDEA Workbook of Financial Reports                  XLSX    447K 
47: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   4.36M 
11: EX-101.INS  XBRL Instance -- unh-20141231                        XML   6.68M 
13: EX-101.CAL  XBRL Calculations -- unh-20141231_cal                XML    313K 
14: EX-101.DEF  XBRL Definitions -- unh-20141231_def                 XML   1.53M 
15: EX-101.LAB  XBRL Labels -- unh-20141231_lab                      XML   2.64M 
16: EX-101.PRE  XBRL Presentations -- unh-20141231_pre               XML   1.75M 
12: EX-101.SCH  XBRL Schema -- unh-20141231                          XSD    252K 
56: ZIP         XBRL Zipped Folder -- 0000731766-15-000007-xbrl      Zip    458K 


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  UNH EX 32.1 12.31.2014  


EXHIBIT 32.1
CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Certification of Principal Executive Officer
In connection with the report of UnitedHealth Group Incorporated (the “Company”) on Form 10-K for the period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen J. Hemsley, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
 
Chief Executive Officer

Certification of Principal Financial Officer
In connection with the report of UnitedHealth Group Incorporated (the “Company”) on Form 10-K for the period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David S. Wichmann, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


 
 
President and Chief Financial Officer




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/10/153,  4,  8-K
For Period end:12/31/1411-K,  ARS
 List all Filings 
Top
Filing Submission 0000731766-15-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 6:45:45.1am ET